Surgery Partners Inc. (SGRY)
NASDAQ:SGRY
Want to see SGRY full AI Analyst Report?
SGRY Stock Chart & Stats
$14.00
$0.26(1.26%)
At close: 4:00 PM EST
$14.00
$0.26(1.26%)
Day’s Range― - ―
52-Week Range$11.41 - $24.10
Previous CloseN/A
Volume149.01K
Average Volume (3M)1.56M
Market Cap
$1.80B
Enterprise Value$5.59B
Total Cash (Recent Filing)$182.30M
Total Debt (Recent Filing)$4.03B
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Aug 04, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.59
Shares Outstanding130,788,160
10 Day Avg. Volume1,284,995
30 Day Avg. Volume1,557,768
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)1.15
Price to Sales (P/S)0.59
P/FCF Ratio10.05
Enterprise Value/Market Cap3.11
Enterprise Value/Revenue1.67
Enterprise Value/Gross Profit7.72
Enterprise Value/Ebitda5.75
Forecast
1Y Price Target
$17.94Price Target Upside28.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)0.39
Revenue Forecast (FY)$3.41B
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationSurgery Partners generates stable operating and free cash flow (operating CF roughly $274M–$300M and FCF ~ $196M in 2025). That persistent cash generation supports capital reinvestment, debt service and selective M&A over the medium term, improving resilience versus cyclical volume dips.
Steady Revenue And EBITDA MarginsTop‑line growth and mid‑teens+ EBITDA margins reflect durable demand for outpatient surgical services and operating leverage. Consistent revenue expansion and EBITDA margins provide a foundation for margin recovery and cash flow conversion as the company executes portfolio optimization and acuity shift strategies.
Physician Partnerships & Robotics-led AcuityThe physician‑partner JV model plus active recruiting and robotics adoption drive higher‑acuity case mix (notably joint growth +14.6%) and expand services capture. These structural assets boost case complexity, payer mix potential, and long‑term organic growth visibility across the ASC footprint.
Bears Say
High Leverage BurdenMaterial leverage constrains financial flexibility and raises refinancing and covenant sensitivity. With net debt several turns of EBITDA, slower volume or reimbursement shocks could force tougher capital allocation choices, limit M&A optionality, and elevate cash interest outlays over the medium term.
Persistent Net LossesDespite positive EBITDA, GAAP net losses and negative ROE reflect ongoing non‑operating costs and interest impact. Continued losses reduce retained earnings, limit balance sheet buildup and make deleveraging slower, constraining strategic investments and shareholder return options over time.
Working Capital And Collections DragRelatively long receivable cycles and DSO ~66 days weaken cash conversion and amplify leverage strain given sizable debt. Persistent collection inefficiencies make free cash flow more volatile and reduce the effective buffer for servicing debt or funding de novos without incremental financing.
Surgery Partners News
SGRY FAQ
What was Surgery Partners Inc.’s price range in the past 12 months?
Surgery Partners Inc. lowest stock price was $11.41 and its highest was $24.10 in the past 12 months.
What is Surgery Partners Inc.’s market cap?
Surgery Partners Inc.’s market cap is $1.80B.
When is Surgery Partners Inc.’s upcoming earnings report date?
Surgery Partners Inc.’s upcoming earnings report date is Aug 04, 2026 which is in 62 days.
How were Surgery Partners Inc.’s earnings last quarter?
Surgery Partners Inc. released its earnings results on May 05, 2026. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.124 by $0.094.
Is Surgery Partners Inc. overvalued?
According to Wall Street analysts Surgery Partners Inc.’s price is currently Undervalued.
Does Surgery Partners Inc. pay dividends?
Surgery Partners Inc. does not currently pay dividends.
What is Surgery Partners Inc.’s EPS estimate?
Surgery Partners Inc.’s EPS estimate is 0.06.
How many shares outstanding does Surgery Partners Inc. have?
Surgery Partners Inc. has 130,788,160 shares outstanding.
What happened to Surgery Partners Inc.’s price movement after its last earnings report?
Surgery Partners Inc. reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.124. Following the earnings report the stock price went up 0.423%.
Which hedge fund is a major shareholder of Surgery Partners Inc.?
Currently, no hedge funds are holding shares in SGRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Surgery Partners Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.94 (28.17% Upside)
$17.94 (28.17% Upside)
Blogger Sentiment
Bullish
SGRY Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 8.9%
Last 30 Days ▼ 8.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.12%
12-Months-Change
Fundamentals
Return on Equity
-4.43%
Trailing 12-Months
Asset Growth
1.17%
Trailing 12-Months
Company Description
Surgery Partners Inc.
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
SGRY Company Deck
SGRY Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Neutral — The call conveyed cautious optimism: the company reported solid revenue and EBITDA in line with expectations, strong MSK/robotics momentum, physician recruiting progress and reiterated full‑year guidance, but those positives are counterbalanced by below‑trend case growth, payer mix/provider tax headwinds, rising interest expense and elevated leverage that temper near‑term upside.View all SGRY earnings summariesSGRY Stock 12 Month Forecast
Average Price Target
$17.94
▲(28.17% Upside)
Technical Analysis
HCA Healthcare
―
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
39.86% Insiders
26.13% Mutual Funds
4.01% Other Institutional Investors
19.41% Public Companies and
Individual Investors